s6y
Company name or ticker
Search
Opus Genetics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Monday, June 28, 2010
Accession number
0001140361-10-027239
Documents
REXAHN PHARMACEUTICALS 424B5 6-28-2010
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header